Acadia Launches Parkinson’s Campaign to Shine Light on Psychosis Symptoms

(December 1, 2017) – A new disease awareness campaign shines a light on the hallucinations and delusions that can affect half of people who have Parkinson’s disease. Sponsored by Acadia Pharmaceuticals, a TV ad and accompanying website focus on the common but lesser-known non-motor side effects of seeing and hearing things that aren’t real. Acadia is the only drugmaker with an approved treatment for the psychosis that can accompany Parkinson’s. Read more…